Thyrotoxic periodic paralysis. Effect of propranolol.
D000086:Acetazolamide / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D005947:Glucose / Q000008:administration & dosage; D005951:Glucose Tolerance Test; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000150:complications*; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D008297:Male; D010243:Paralysis / Q000209:etiology / Q000517:prevention & control*; D010507:Periodicity; D011188:Potassium / Q000097:blood; D011433:Propranolol / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood
D001786:Blood Glucose; D004040:Dietary Carbohydrates; D007328:Insulin; D012964:Sodium; D011433:Propranolol; D005947:Glucose; D000086:Acetazolamide; D011188:Potassium